Photo Gallery



News & Updation

  • Updated Version
  • WJPPS introducing updated version of OSTS (online submission and tracking system), which have dedicated control panel for both author and reviewer. Using this control panel author can submit manuscript
  • Call for Paper
    • WJPPS  Invited to submit your valuable manuscripts for Coming Issue.
  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.
  • WJPPS Impact Factor
  • Its our Pleasure to Inform you that WJPPS Impact Factor has been increased from  7.454 to 7.632  due to high quality Publication at International Level

  • ICV
  • WJPPS Rank with Index Copernicus Value 84.65 due to high reputation at International Level

  • JUNE 2021 Issue has been successfully launched on 1 June 2021.



Magd Gamil Alshargabi* and Deepak Kumar Jha


Asthma is a very common chronic disease. Most patients have their asthma controlled with standard therapies such as beta 2 agonists and/or inhaled corticosteroids. However, patients with severe asthma may need an adjunctive biological therapy to control their symptoms. Omalizumab was the first and for a long time the only biological drug available for the add-on therapy of uncontrolled asthma. Treatment with omalizumab is reported to have significant benefits for patients with moderate to severe persistent allergic asthma that is not sufficiently controlled with regular therapies. Additionally, omalizumab showed a promising potential beyond its current label, such as for enabling/facilitating immunotherapy and in patients with nonatopic asthma. However, further studies are needed in order to demonstrate the safety and efficacy of omalizumab therapy in these indications.

Keywords: Asthma, Omalizumab, Chronic Disease, Adjunctive Biological Therapy.

[Full Text Article]

Call for Paper

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Online Submission

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Email & SMS Alert

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More